Post Profile






New Therapeutic Vaccine Approach Holds Promise for HIV Remission

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR), Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV.
read more

share

Related Posts


Vaccine Candidates Protect Primates Against Zika Virus

Health : Newswise Medical News

A month after announcing that two promising vaccine candidates provided mice with complete protection against the Zika virus, a research team at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walte...

New therapeutic vaccine approach holds promise for HIV remission

Academics / Chemistry : EurekAlert: Chemistry

(Beth Israel Deaconess Medical Center) The study demonstrates combining an experimental vaccine with innate immune stimulant may help lead to viral remission in patients with HIV/AIDS. The combination approach decreased levels of vi...

Top HIV Scientists Awarded $42 Million in National Institutes of Health Funding to Improve Efficacy of HIV Vaccine Platforms

Health : Newswise Medical News

With $42 million in funding from the National Institutes of Health, scientists from Beth Israel Deaconess Medical Center (BIDMC) and Oregon Health & Science University (OHSU) will lead a five-year research initiative to advance effo...

Vaccine candidates protect against Zika virus in rhesus monkeys

Academics / General Science : Science Codex

SILVER SPRING, Md. - The Walter Reed Army Institute of Research (WRAIR), in collaboration with the Beth Israel Deaconess Medical Center and Harvard Medical School, has completed a second round of preclinical studies on a promising Z...

New preclinical study indicates vaccine to prevent Zika infection in humans is feasible

Academics / General Science : ScienceDaily: Science Society

The Walter Reed Army Institute of Research (WRAIR) and collaborators at the Beth Israel Deaconess Medical Center and Harvard Medical School have completed a promising preclinical study of two Zika vaccine candidates that suggests th...

Comments


Copyright © 2016 Regator, LLC